Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Masimo (MASI) Change in Acquisitions & Divestments (2010 - 2021)

Masimo's quarterly Change in Acquisitions & Divestments came in at $190.0 million in Q1 2021, up 375.0% year-on-year from $40.0 million in Q1 2020, and up 371.43% quarter-over-quarter from -$70.0 million in Q1 2020.

Masimo has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $190.0 million in Q1 2021.

  • For the quarter ending Q1 2021, Change in Acquisitions & Divestments rose 375.0% year-over-year to $190.0 million; the trailing twelve-month figure through Oct 2021 stood at $190.0 million (up 733.33% YoY), and the FY2021 full-year result was $120.0 million, down 25.0% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2021 stood at $190.0 million, up from -$70.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $190.0 million in Q1 2021, with the low at -$70.0 million in Q1 2020.
  • Average Change in Acquisitions & Divestments over 3 years is $56.0 million, with a median of $40.0 million recorded in 2019.
  • Year-over-year, Change in Acquisitions & Divestments tumbled 138.89% in 2020 and jumped 375.0% in 2021.
  • Tracing MASI's Change in Acquisitions & Divestments over 3 years: stood at $40.0 million in 2019, then slumped by 275.0% to -$70.0 million in 2020, then jumped by 371.43% to $190.0 million in 2021.
  • The last three Change in Acquisitions & Divestments figures came in at $190.0 million (Q1 2021), -$70.0 million (Q1 2020), and $40.0 million (Q4 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Masimo 9.32 Bn 9.20 Bn 250.80 Mn

Historic Data

Download Data 🔒
DateValue
Jan 2, 2021 190.00 Mn
Jan 2, 2021 190.00 Mn
Mar 28, 2020 -70.00 Mn
Mar 28, 2020 -70.00 Mn
Dec 28, 2019 40.00 Mn
Dec 28, 2019 40.00 Mn
Sep 28, 2019 -60.00 Mn
Sep 28, 2019 -60.00 Mn
Mar 30, 2019 180.00 Mn
Mar 30, 2019 180.00 Mn
Jul 3, 2010 75.99 Mn
Jul 3, 2010 75.99 Mn
Apr 3, 2010 56.99 Mn
Apr 3, 2010 56.99 Mn